APTABIO THERAPEUTICS INC. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6,010 KRW | +0.17% |
|
-2.91% | -33.59% |
Business Summary
Sales per Business
| KRW in Million | 2022 | Weight | 2023 | Weight | Delta |
|---|---|---|---|---|---|
Product Sales (ODM)
64.8
%
| - | - | 210 | 64.8 % | - |
Product Sales (General)
19.1
%
| - | - | 62 | 19.1 % | - |
Reagent
16.2
%
| 48 | 100.0 % | 52 | 16.2 % | +8.19% |
Sales per region
| KRW in Million | 2022 | Weight | 2023 | Weight | Delta |
|---|---|---|---|---|---|
South Korea
100.0
%
| 48 | 100.0 % | 324 | 100.0 % | +569.80% |
Managers
| Managers | Title | Age | Since |
|---|---|---|---|
Su-Jin Lee
FOU | Founder | 55 | 24/09/24 |
Sung-Hwan Moon
PSD | President | 65 | - |
Jun-Hee Jung
DFI | Director of Finance/CFO | 54 | - |
Jung-Ho Park
AUD | Comptroller/Controller/Auditor | 53 | - |
Members of the board
| Members of the board | Title | Age | Since |
|---|---|---|---|
Su-Jin Lee
FOU | Founder | 55 | 24/09/24 |
Jong-Nam Suh
BRD | Director/Board Member | 62 | - |
Sung-Hwan Moon
PSD | President | 65 | - |
Share class
| Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
|---|---|---|---|---|---|
| Stock A | 1 | 22,298,866 | 14,602,673 ( 65.49 %) | 0 | 65.49 % |
| Stock B | 0 | 1,037,574 | 0 | 0 |
Company contact information
Sector
Sales per Business
| 1st Jan change | Capi. | |
|---|---|---|
| -33.59% | 97.99M | |
| +3.91% | 108B | |
| +10.87% | 104B | |
| +1.28% | 22.33B | |
| -13.14% | 22.19B | |
| -7.05% | 18.69B | |
| -38.36% | 17.74B | |
| -10.66% | 17.64B | |
| +3.75% | 14.05B | |
| +36.70% | 12.51B |
- Stock Market
- Equities
- A293780 Stock
- Company AptaBio Therapeutics Inc.